SCHEMBL8934531

SCHEMBL8934531

COc1ccc(-c2cc(=O)c3cccc(C(C)C)c3o2)cc1OC

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ABCB1 P08183 4/20 0.67
▸ ABCG2 Q9UNQ0 4/20 0.67
▸ ABCC1 P33527 2/20 0.67
▸ CYP3A4 P08684 6/20 0.63
▸ MAPT P10636 6/20 0.63
▸ ALDH1A1 P00352 5/20 0.63
▸ HPGD P15428 5/20 0.63
▸ KDM4E B2RXH2 4/20 0.63
▸ MAPK1 P28482 4/20 0.63
▸ HSD17B10 Q99714 3/20 0.63
▸ MEN1 O00255 3/20 0.63
▸ KMT2A Q03164 3/20 0.63
▸ SMN1; SMN2 Q16637 2/20 0.63
▸ GLA P06280 1/20 0.63
▸ THRB P10828 1/20 0.63
▸ TERT O14746 4/20 0.61
▸ CYP1A1 P04798 2/20 0.60
▸ CYP1B1 Q16678 2/20 0.60
▸ CYP1A2 P05177 1/20 0.60
▸ CSNK2A2 P19784 2/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8934503 0.89 TERT (0.67) ABCB1ABCG2ABCC1CYP3A4MAPT
SCHEMBL29361605 0.80 ABCG2 (1.00) ABCB1ABCG2ABCC1CYP3A4MAPT
SCHEMBL4650074 0.80 ABCG2 (1.00) ABCB1ABCG2ABCC1CYP3A4MAPT
SCHEMBL13264829 0.80 CYP1B1 (0.60) ABCB1ABCG2ABCC1CYP3A4MAPT
SCHEMBL29612043 0.79 TERT (0.77) ABCB1ABCG2ABCC1CYP3A4MAPT
SCHEMBL988001 0.79 TERT (0.77) ABCB1ABCG2ABCC1CYP3A4MAPT
3',4'-Dimethoxyflavone SCHEMBL29623082 0.78 CYP3A4 (1.00) ABCB1ABCG2ABCC1CYP3A4MAPT
3',4'-Dimethoxyflavone SCHEMBL1675954 0.78 CYP3A4 (1.00) ABCB1ABCG2ABCC1CYP3A4MAPT
3',4'-Dimethoxyflavone SCHEMBL28140373 0.76 CYP3A4 (0.97) ABCB1ABCG2ABCC1CYP3A4MAPT
SCHEMBL30626954 0.76 CYP3A4 (0.76) ABCB1ABCG2CYP3A4MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1996031206-A2 FLAVONES AND COUMARINS AS AGENTS FOR THE TREATMENT OF ATHEROSCLEROSIS WARNER-LAMBERT COMPANY (US) 1996-10-10 — — WO disclosed
Send feedback